Foster Dykema Cabot & Co’s Bio-Techne TECH Stock Holding History

Foster Dykema Cabot & Co’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-85	Closed	-$7K	–	386
2023 Q2	$7K	Buy	+85	New	+$6.83K	﹤0.01%	283

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Foster Dykema Cabot & Co's TECH Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 85 shares — an estimated $7K sold.

Foster Dykema Cabot & Co first reported a position in TECH in Q2 2023 and held it in 1 quarter. The position peaked at $7K in Q2 2023. 529 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Foster Dykema Cabot & Co reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
Foster Dykema Cabot & Co sold 85 Bio-Techne shares in Q3 2023, an estimated $7K.
Foster Dykema Cabot & Co first reported a position in Bio-Techne in Q2 2023 and held it in 1 quarter.
Foster Dykema Cabot & Co's Bio-Techne position peaked at $7K in Q2 2023.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.